摘要
目的:评价小儿呼吸道合胞病毒肺炎中西医对照治疗的临床疗效和成本-效果比。方法:按中药和西药治疗方法将216例痰热闭肺证型患者分为中药组和西药组,运用药物经济学的成本-效果分析方法进行评价。结果:中药和西药组的愈显率分别为87.83%和79.21%,两组比较无统计学意义(P>0.05),但直接治疗成本有统计学意义(P<0.05),中药组优于西药组。结论:中药与西药治疗小儿呼吸道合胞病毒肺炎疗效相同,但中药治疗有成本优势。
Objective：This study is conducted to compare the cost -effect ratio between the traditional Chinese and western medicine treatment of pediatric respiratory syncytial virus pneumonia. Methods ：216 of phlegm-heat blocking lung syndrome were allocated to the traditional Chinese medicine treatment （ study group） and western medicine treatment （ control group）. The two treatments were compared by cost-effect of ratio. Results ： Comparison of efficacy between groups ： the efficacy respectively was 87. 83 % and 79.21% in the study and control groups, there was no significant difference （P 〉 0. 05 ）. But the direct treatment costs had significant difference （ P 〈 0. 05 ）, traditional Chinese medicine group was superior to control group. Conclusion ： The two groups have the same efficacy in treating phlegm - heat blocking lung syndrome of RSV pneumonia, but the treatment with traditional Chinese medicine regimen has a cost advantage.
出处
《辽宁中医杂志》
CAS
2013年第6期1188-1189,共2页
Liaoning Journal of Traditional Chinese Medicine
关键词
呼吸道合胞病毒肺炎
中西医对照治疗
成本一效果比
直接治疗成本
respiratory syneytial virus pneumonia
integrated traditional Chinese and western medicine treatment
cost-effect ratio
direct treatment costs
